Evidence-based patient information on the prevention of heart attack in type 2 diabetes Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Two study groups will be compared:
Intervention group: ISDM program consisting of a decision aid booklet and a curriculum for group counseling.
Control group: Placebo counseling, i.e. a program simi
Sponsors
European Foundation for the Study of Diabetes (EFSD) (Germany)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients (men and women) are eligible with type 2 diabetes 2. Aged between 45 and 69 years 3. With no previous diagnosis of ischemic heart disease (ICD I20-I25) 4. With former participation in Decision Making (DMP) education programs for type 2 diabetes 5. HbA1c-values between 6 and 9%
Exclusion criteria
Exclusion criteria: Patients will be excluded if they have: 1. Cognitive disorders 2. Proliferative retinopathy 3. Chronic kidney disease stage three or higher [Kidney Disease Outcomes Quality Initiative (KDOQI)] 4. Addiction to alcohol 5. Metastatic cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The patients' comprehension of heart attack prevention that includes the understanding of the concept of risk, the notion of heart attack risk, and the benefits and harms of preventative measures. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Adherence to the individual treatment goals regarding statin treatment, blood-pressure treatment, glucose control, and smoking cessation 2. Adherence to the preventative option prioritized by the individual patient | — |
Countries
Germany
Outcome results
None listed